Serina completes sentinel dosing in Cohort 1 of Phase 1b trial of SER-252
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual…
Read the full article3h agoen
You might also wanna read
Veteran Energy Analyst: “Crude Oil Is Not the Problem.” Here’s What’s Keeping Gas Prices High.
24/7 Wall St.·11m ago
SandboxAQ CEO: “It’s Time That America Really Has a Sovereign Wealth Fund.” Why America Should Copy Norway’s $2 Trillion Fund
24/7 Wall St.·11m ago
TBPN’s John Coogan: “People Can’t Really Complain.” Here’s Why Blue Origin Is Worth $130 Billion.
24/7 Wall St.·17m ago
Cboe data shows mixed options sentiment in Boeing with shares down 0.54%
thefly.com·36m ago
Palo Alto Just Soared 28% in a Month. Should Investors Take Profits and Rotate Into CrowdStrike or Fortinet?
24/7 Wall St.·39m ago
Volkswagen says model lineup to be streamlined by up to 50%
thefly.com·42m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.